XU Dong, CHEN Jiangyun, CAI Yiyuan. Past and Present of Implementation Science (PartⅠ)—Origin and Development[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 442-449. DOI: 10.12290/xhyxzz.2024-0023
Citation: XU Dong, CHEN Jiangyun, CAI Yiyuan. Past and Present of Implementation Science (PartⅠ)—Origin and Development[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 442-449. DOI: 10.12290/xhyxzz.2024-0023

Past and Present of Implementation Science (PartⅠ)—Origin and Development

Funds: 

National Natural Science Foundation of China 72164005

Swiss Agency for Development and Cooperation 81067392

More Information
  • Corresponding author:

    CAI Yiyuan, E-mail: caiyiyuan@gmc.edu.cn

  • Received Date: January 11, 2024
  • Accepted Date: February 19, 2024
  • Available Online: March 05, 2024
  • Issue Publish Date: March 29, 2024
  • Implementation science aims to close the gap between knowledge and practice by fostering the uptake and implementation of evidence-based practices. In Europe and America, implementation science is rapidly evolving and improving. In China, the field is still in its infancy. This paper focuses on the definition, origin, domestic and international development, research hotspots, challenges, and opportunities of implementation science. Although implementation science is still at an early stage in China, it has shown rapid development momentum. Chinese scholars, therefore, should leverage China's distinctive research environment to conduct high-quality and innovation implementation studies in order to excel in implementation science areas and lead globally.
  • [1]
    Bauer M S, Kirchner J A. Implementation science: What is it and why should I care?[J]. Psychiatry Res, 2020, 283: 112376. DOI: 10.1016/j.psychres.2019.04.025
    [2]
    Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence[J]. Lancet, 2009, 374(9683): 86-89. DOI: 10.1016/S0140-6736(09)60329-9
    [3]
    National Institute of Health. Implementation science news, resources and funding for global health researchers[EB/OL]. [2024-02-16]. https://www.fic.nih.gov/researchtopics/pages/implementationscience.aspx.
    [4]
    Odeny T A, Padian N, Doherty M C, et al. Definitions of implementation science in HIV/AIDS[J]. Lancet HIV, 2015, 2(5): e178-e180. DOI: 10.1016/S2352-3018(15)00061-2
    [5]
    Eccles M P, Mittman B S. Welcome to implementation science[J]. Implement Sci, 2006, 1: 1. DOI: 10.1186/1748-5908-1-1
    [6]
    Eccles M P, Foy R, Sales A, et al. Implementation science six years on-our evolving scope and common reasons for rejection without review[J]. Implement Sci, 2012, 7: 71. DOI: 10.1186/1748-5908-7-71
    [7]
    Metz A, Jensen T, Farley A, et al. Is implementation research out of step with implementation practice? Pathways to effective implementation support over the last decade[J]. Implement Res Pract, 2022, 3: 26334895221105585.
    [8]
    Allison M, Albers B, Katie M, et al. Implementation Practice in Human Service Systems: Understanding the Principles and Competencies of Professionals Who Support Implementation[J/OL]. (2021-03-15)[2024-01-12]. https://www.tandfonline.com/doi/full/10.1080/23303131.2021.1895401.
    [9]
    Hoke T. Implementation research: The unambiguous cornerstone of implementation science[EB/OL]. (2018-02-06)[2024-01-12]. https://researchforevidence.fhi360.org/implementation-research-the- unambiguous-cornerstone-of-imple- mentation-science.
    [10]
    Mellis C. Evidence-based medicine: what has happened in the past 50 years?[J]. J Paediatr Child Health, 2015, 51(1): 65-68. DOI: 10.1111/jpc.12800
    [11]
    Lang E S, Wyer P C, Haynes R B. Knowledge translation: closing the evidence-to-practice gap[J]. Ann Emerg Med, 2007, 49(3): 355-363. DOI: 10.1016/j.annemergmed.2006.08.022
    [12]
    Glasgow R E, Vinson C, Chambers D, et al. National institutes of health approaches to dissemination and implementa-tion science: current and future directions[J]. Am J Public Health, 2012, 102(7): 1274-1281. DOI: 10.2105/AJPH.2012.300755
    [13]
    Wang Y X, Wong E L Y, Nilsen P, et al. A scoping review of implementation science theories, models, and frameworks-an appraisal of purpose, characteristics, usability, applicability, and testability[J]. Implement Sci, 2023, 18(1): 43. DOI: 10.1186/s13012-023-01296-x
    [14]
    The Lancet Global Health. Implementing implementation science in global health[J]. Lancet Glob Health, 2023, 11(12): e1827. DOI: 10.1016/S2214-109X(23)00523-5
    [15]
    Norton W E, Lungeanu A, Chambers D A, et al. Mapping the growing discipline of dissemination and implementation science in health[J]. Scientometrics, 2017, 112(3): 1367-1390. DOI: 10.1007/s11192-017-2455-2
    [16]
    国家自然科学基金委员会. 2017年度国家自然科学基金委员会(NSFC) 与加拿大卫生研究院(CIHR) 精神健康与痴呆症实施性合作研究项目指南[EB/OL]. (2016-12-30)[2024-01-12]. https://www.nsfc.gov.cn/publish/portal0/tab442/info61110.htm.

    National Natural Science Foundation of China. Notice of Approval for the 2017 National Natural Science Foundation of China (NSFC) and Canadian Institutes of Health (CIHR) collaborative research program on mental health and dementia implementation[EB/OL]. (2016-12-30)[2024-01-12]. https://www.nsfc.gov.cn/publish/portal0/tab442/info61110.htm.
    [17]
    Landes S J, McBain S A, Curran G M. An introduction to effectiveness-implementation hybrid designs[J]. Psychiatry Res, 2019, 280: 112513. DOI: 10.1016/j.psychres.2019.112513
    [18]
    Waltz T J, Powell B J, Matthieu M M, et al. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study[J]. Implement Sci, 2015, 10: 109. DOI: 10.1186/s13012-015-0295-0
    [19]
    Gaynes B N, Akiba C F, Hosseinipour M C, et al. The Sub-Saharan Africa Regional Partnership (SHARP) for mental health capacity-building scale-up trial: study design and protocol[J]. Psychiatr Serv, 2021, 72(7): 812-821. DOI: 10.1176/appi.ps.202000003
    [20]
    Faija C L, Gellatly J, Barkham M, et al. Enhancing the behaviour change wheel with synthesis, stakeholder involve-ment and decision-making: a case example using the 'enhancing the quality of psychological interventions delivered by telephone' (Equity) research programme[J]. Implement Sci, 2021, 16(1): 53. DOI: 10.1186/s13012-021-01122-2
    [21]
    Bing A, Spiegelman D, Nevo D, et al. Learn-As-you-GO (LAGO) trials: optimizing treatments and preventing trial failure through ongoing learning[EB/OL]. (2023-07-13)[2024-02-16]. https://arxiv.org/abs/2307.06552.
    [22]
    Wiltsey Stirman S, Baumann A A, Miller C J. The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions[J]. Implement Sci, 2019, 14(1): 58. DOI: 10.1186/s13012-019-0898-y
    [23]
    Miller C J, Barnett M L, Baumann A A, et al. The FRAME-IS: a framework for documenting modifications to implementation strategies in healthcare[J]. Implement Sci, 2021, 16(1): 36.
  • Related Articles

    [1]LIU Shupeng, YU Mengyang, WU Xiaofei, WANG Hongyun. Clinical Landscape of Therapeutic Cancer Vaccines: Challenges and Opportunities[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1356-1363. DOI: 10.12290/xhyxzz.2024-0130
    [2]KE Dandan, JIA Nan, CUI Puan, HE Zhong. Current Situation, Challenges and Suggestions for the Development of Primary Health Care Services in China in the Post Pandemic Era[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 45-51. DOI: 10.12290/xhyxzz.2023-0290
    [3]LI Yi, XU Yingchun. A New Chapter in the COVID-19 Pandemic: the Characteristics of Omicron Variant and A New Step for Scientific Epidemic Prevention and Control[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 9-17. DOI: 10.12290/xhyxzz.2022-0697
    [4]FANG Yuan, PAN Yuanlong, ZHU Baoli. Human Gut Microbiome and Diseases: Current Status, Opportunity and Challenges[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 713-718. DOI: 10.12290/xhyxzz.2022-0288
    [5]Initiative to Promote the Development of Patient and Public Versions of Guidelines in China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 670-672. DOI: 10.12290/xhyxzz.2022-0378
    [6]ZHANG Zhifei, YANG Zhengxin, HUANG Yunyou, ZHAN Jianfeng. Big Medical Data and Medical AI Standards: Status Quo, Opportunities and Challenges[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 614-620. DOI: 10.12290/xhyxzz.2021-0472
    [7]Chen-xi YU, Shui SUN. Roles of Long Noncoding RNAs in the Development and Progression of Osteoarthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 85-90. DOI: 10.3969/j.issn.1674-9081.20170138
    [8]Enhanced Recovery Pathways: the Direction in the Future[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 553-556. DOI: 10.3969/j.issn.1674-9081.2019.06.001
    [9]Hengjun Gao, Lili Du, Xiaoyan Zhang, Kehao Zhang, Yang Ye. Status, Opportunities and Challenges of Biobanks[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(2): 172-176. DOI: 10.3969/j.issn.1674-9081.2018.02.013
    [10]Bo XIAO, Luo ZHOU. The Latest Clinical Guidelines for Diagnosis and Treatment of Epilepsy: Coexistence of Opportunities and Challenges[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 122-126. DOI: 10.3969/j.issn.1674-9081.2017.03.008
  • Cited by

    Periodical cited type(4)

    1. 黄念文,李海松,王彬,王伊光,冯隽龙,孙龙吉,王继升. 基于肠道菌群探讨活血化瘀法治疗勃起功能障碍. 中医学报. 2024(05): 924-928 .
    2. 刘喆雯,陈其华. 基于肠道菌群从“土郁夺之”论治慢性前列腺炎. 中国中医药信息杂志. 2024(05): 15-20 .
    3. 陈瑞泽,李瑞仕,郭峰,王泽坤. 基于肠道微生态探讨推拿治疗孤独症谱系障碍的思路. 江西中医药. 2024(09): 76-80 .
    4. 黄念文,王彬,王继升,赵琦,冯隽龙,孙龙吉,李海松. 论肠道菌群是补肾活血法治疗慢性前列腺炎的重要靶点. 湖南中医药大学学报. 2023(03): 565-570 .

    Other cited types(1)

Catalog

    Article Metrics

    Article views (2222) PDF downloads (636) Cited by(5)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close